Myron Wentz
Founder presso USANA HEALTH SCIENCES, INC.
Patrimonio netto: 382 M $ in data 31/03/2024
Posizioni attive di Myron Wentz
Società | Posizione | Inizio | Fine |
---|---|---|---|
USANA HEALTH SCIENCES, INC. | Director/Board Member | 01/05/2020 | - |
Founder | 01/09/1992 | - | |
Chief Executive Officer | 01/09/1992 | 23/07/2008 | |
Chairman | 01/09/1992 | - |
Storia della carriera di Myron Wentz
Precedenti posizioni note di Myron Wentz
Società | Posizione | Inizio | Fine |
---|---|---|---|
IMMUNOSYN CORP | Director/Board Member | 14/03/2008 | 20/03/2009 |
Gull Laboratories, Inc.
Gull Laboratories, Inc. Medical SpecialtiesHealth Technology Part of Meridian Bioscience, Inc., Gull Laboratories, Inc. is a private company that specializes in surgical and medical instruments as well as drugs. The company is based in Salt Lake City, UT. The company was founded by Myron W. Wentz. Gull Laboratories was acquired by Meridian Bioscience, Inc. from Fresenius SE & Co. KGaA on November 05, 1998 for $18.04 million. | Chairman | 01/01/1974 | 01/01/1998 |
Founder | 01/01/1974 | 01/01/1998 | |
Sanoviv SA de CV | Founder | 01/01/1998 | - |
Formazione di Myron Wentz
University of Utah | Doctorate Degree |
North Central College | Undergraduate Degree |
University of North Dakota | Graduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 7 |
Messico | 2 |
Posizioni
Founder | 3 |
Director/Board Member | 2 |
Chairman | 2 |
Settori
Health Technology | 4 |
Consumer Services | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
USANA HEALTH SCIENCES, INC. | Health Technology |
Aziende private | 3 |
---|---|
Gull Laboratories, Inc.
Gull Laboratories, Inc. Medical SpecialtiesHealth Technology Part of Meridian Bioscience, Inc., Gull Laboratories, Inc. is a private company that specializes in surgical and medical instruments as well as drugs. The company is based in Salt Lake City, UT. The company was founded by Myron W. Wentz. Gull Laboratories was acquired by Meridian Bioscience, Inc. from Fresenius SE & Co. KGaA on November 05, 1998 for $18.04 million. | Health Technology |
Immunosyn Corp.
Immunosyn Corp. BiotechnologyHealth Technology Immunosyn Corp. is a development stage company. It engages in the marketing, distribution, and sale of a biopharmaceutical drug product SF-1019, which is used for the treatment of various diseases and pathological conditions, including chronic inflammatory demyelinating polyneuropathy, diabetic neuropathy, and diabetic ulcers. The company was founded in August 2006 and is headquartered in San Diego, CA. | Health Technology |
Sanoviv SA de CV |
- Borsa valori
- Insiders
- Myron Wentz
- Esperienza